Search Results - "Sader, Mark A"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Physiological testosterone replacement and arterial endothelial function in men by Sader, Mark A., Griffiths, Kaye A., Skilton, Michael R., Wishart, Susan M., Handelsman, David J., Celermajer, David S.

    Published in Clinical endocrinology (Oxford) (01-07-2003)
    “…Summary objective The vascular effects of fluctuations in testosterone levels within the physiological range in otherwise healthy men are not known. We…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Dihydrotestosterone Promotes Vascular Cell Adhesion Molecule-1 Expression in Male Human Endothelial Cells via a Nuclear Factor-κB-Dependent Pathway by Death, Alison K, McGrath, Kristine C. Y, Sader, Mark A, Nakhla, Shirley, Jessup, Wendy, Handelsman, David J, Celermajer, David S

    Published in Endocrinology (Philadelphia) (01-04-2004)
    “…There exists a striking gender difference in atherosclerotic vascular disease. For decades, estrogen was considered atheroprotective; however, an alternative…”
    Get full text
    Journal Article
  4. 4

    Androgenic anabolic steroids and arterial structure and function in male bodybuilders by Sader, Mark A, Griffiths, Kaye A, McCredie, Robyn J, Handelsman, David J, Celermajer, David S

    “…OBJECTIVES The study examined arterial and cardiac structure and function in bodybuilders using androgenic anabolic steroids (AAS), compared to…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis by Sader, Mark A., McGrath, Kristine C. Y., Hill, Michelle D., Bradstock, Ken F., Jimenez, Mark, Handelsman, David J., Celermajer, David S., Death, Alison K.

    Published in Clinical endocrinology (Oxford) (01-01-2005)
    “…Summary Objective  There is evidence that male sex hormones influence the rate of progression of inflammatory and cardiovascular diseases. We have previously…”
    Get full text
    Journal Article
  6. 6

    Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease by Griffiths, Kaye A, Sader, Mark A, Skilton, Michael R, Harmer, Jason A, Celermajer, David S

    “…We sought to assess the effects of raloxifene, a selective estrogen receptor modulator, on arterial physiology and biology in postmenopausal women with…”
    Get full text
    Journal Article
  7. 7

    Percutaneous transcatheter patent foramen ovale closure using the right internal jugular venous approach by Sader, Mark A., De Moor, Michael, Pomerantsev, Eugene, Palacios, Igor F.

    “…Percutaneous transcatheter closure of a patent foramen ovale (PFO) is a therapeutic option in patients with paradoxical embolism. For patients in whom PFO…”
    Get full text
    Journal Article
  8. 8

    Oestradiol improves arterial endothelial function in healthy men receiving testosterone by Sader, Mark A., McCredie, Robyn J., Griffiths, Kaye A., Wishart, Susan M., Handelsman, David J., Celermajer, David S.

    Published in Clinical endocrinology (Oxford) (01-02-2001)
    “…OBJECTIVE To assess prospectively the effects of low dose oestradiol on arterial endothelial and smooth muscle function in healthy men. Oestrogen use is…”
    Get full text
    Journal Article
  9. 9

    Neuropsychological and psychiatric outcomes following coronary surgery or angioplasty: A comparative study by Sader, Mark A., Miller, Laurie A., Caine, Diana, McCredie, Robyn J., Corr, Melissa J., Robertson, Michael, Watson, John D.G., Celermajer, David S.

    Published in Heart, lung & circulation (2002)
    “…Background: Medical outcomes following coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA) are similar, but few…”
    Get full text
    Journal Article
  10. 10

    Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway by Death, Alison K, McGrath, Kristine C Y, Sader, Mark A, Nakhla, Shirley, Jessup, Wendy, Handelsman, David J, Celermajer, David S

    Published in Endocrinology (Philadelphia) (01-04-2004)
    “…There exists a striking gender difference in atherosclerotic vascular disease. For decades, estrogen was considered atheroprotective; however, an alternative…”
    Get full text
    Journal Article
  11. 11
  12. 12